Richard Morris
Director of Finance/CFO at CARISMA THERAPEUTICS, INC.
Net worth: - $ as of 30/04/2024
Richard Morris active positions
Companies | Position | Start | End |
---|---|---|---|
CARISMA THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2021 | - |
Compliance Officer | 01/06/2021 | - | |
Treasurer | 01/06/2021 | - | |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Director of Finance/CFO | 01/06/2021 | - |
Career history of Richard Morris
Former positions of Richard Morris
Companies | Position | Start | End |
---|---|---|---|
PASSAGE BIO, INC. | Director of Finance/CFO | 01/10/2019 | 30/05/2021 |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Director of Finance/CFO | 01/11/2017 | 01/07/2019 |
VITAE PHARMACEUTICALS INC | Director of Finance/CFO | 08/07/2014 | 25/10/2016 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Comptroller/Controller/Auditor | 01/01/2005 | 25/06/2012 |
Corporate Officer/Principal | 25/06/2012 | 01/01/2014 |
Training of Richard Morris
St. Joseph's University | Undergraduate Degree |
Statistics
International
United States | 8 |
Operational
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 7 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
PASSAGE BIO, INC. | Health Technology |
CARISMA THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Richard Morris
- Experience